30
Oct
The Court of Justice of the European Union (the "CJEU") has issued a judgment clarifying the rights of parallel import licence holders. It ruled that the mere expiration of a marketing authorisation of reference does not affect the associated parallel import licence. The parallel importers rights may only be restricted if justified by specific circumstances relating to protecting public health.
Authorities refuse to adjust dosage instructions
Kohlpharma, a German pharmaceutical company, obtained a parallel import licence to import a medicinal product in tablet...